This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Brazil's antitrust agency notifies companies suspected of rigging tenders for educational materials

( September 23, 2015, 13:49 GMT | Official Statement) -- MLex Summary: Brazil's antitrust agency has officially notified Attendy Artigos de Vestuário e Confecções and NCR Uniformes of their suspected involvement in a bid-rigging cartel affecting several states, including Santa Catarina. Antitrust officials couldn't locate the companies, but said that they are under investigation for allegedly rigging tenders for educational materials. The clock will now start running for the companies to submit defenses. The regulator has removed Comciêmcia from the probe because it couldn't locate it. Others under investigation are Brink Mobil Equipamentos Educacionais, Capricórnio, Diana Paolucci Indútria e Comércio, Excel 3000 Materiais e Serviços, Libero Comercial, Mercosul Comercial e Industrial, NicaltexTêxtil, and Tecelagem Guelfi.Official journal entry follows in full in Portuguese....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections